MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Unlock the potential of genetic testing to diagnose FTD/ALS 3, identify C9orf72 mutations, guide treatments, assess family risk, and advance research breakthroughs.
Explore how genetic testing advances the diagnosis and treatment of Frontotemporal Dementia and ALS4, enhancing early detection and personalized care strategies.
Unlock insights into Glioma Susceptibility 9 with genetic testing for early detection, personalized treatment plans, and improved diagnostic accuracy in glioma care.
Explore GPT2 deficiency, a metabolic disorder affecting amino acid metabolism. Genetic testing aids in diagnosis, treatment personalization, and family planning.
Unlock insights into Hereditary Spastic Paraplegia 73. Explore genetic testing's role in diagnosis, family planning, and potential therapies for HSP73 patients.
Unlock genetic insights into Hereditary Spastic Paraplegia 74 with cutting-edge testing, aiding in accurate diagnosis, personalized care, and better family planning.
Uncover how genetic testing transforms the diagnosis and management of hypomyelinating leukodystrophy 10, improving early intervention and personalized care.
Explore how genetic testing for Hypomyelinating Leukodystrophy 11 aids early diagnosis, treatment guidance, family planning, and contributes to crucial research efforts.